赛诺菲的Acomplia 从未获得美国批准,因与自杀念头有关而于 2008 年在欧洲被撤回。
Acomplia 旨在修改调节食欲的神经系统部分。Wegovy 等新型减肥药通过模仿肠道激素来调节食欲,而不是直接干扰大脑化学物质。
Orexigen Therapeutics 的减肥药 Contrave 和 Vivus Inc...查看全文
WilAkoto中概垃圾车2020-07-08 06:54
$VIVUS(VVUS)$ vivus要重组了,暂时不破产就是换老大IEH Bio把vivus小弟收了,七月2号之前认大哥的发5百万美金💲一人💵0.28,如果到了2021/2022小弟们干得好再发美金💲2块,这个听听算了……这年头好大哥不多查看全文
$Vivus(VVUS)$ 内部交易: 2017-03-09,10% Owner,NORTH TIDE CAPITAL, LLC ,卖出,722400普通股, $1.21
$Vivus(VVUS)$ 内部交易: 2017-03-08,10% Owner,NORTH TIDE CAPITAL, LLC ,卖出,350000普通股, $1.05
$Vivus(VVUS)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-08 AccNo: 0001558370-17-001460 Size: 13 MB 网页链接
$Vivus(VVUS)$ 8-K - Current report Filed: 2017-03-08 AccNo: 0001104659-17-015194 Size: 214 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Vivus(VVUS)$ 美东时间 2017-03-08 盘后 披露财报,预期EPS -0.09 网页链接
$Vivus(VVUS)$ 内部交易: 2017-02-27,10% Owner,NORTH TIDE CAPITAL, LLC ,卖出,150000普通股, $1.13
$Vivus(VVUS)$ 内部交易: 2017-02-24,10% Owner,NORTH TIDE CAPITAL, LLC ,卖出,33000普通股, $1.14
$Vivus(VVUS)$ 内部交易: 2017-02-23,10% Owner,NORTH TIDE CAPITAL, LLC ,卖出,150000普通股, $1.16
$Vivus(VVUS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-15 AccNo: 0001104659-17-009564 Size: 241 KB 网页链接
$Vivus(VVUS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0000929638-17-000184 Size: 85 KB 网页链接